Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 79.10
-0.50 (-0.63%)
Nov 19, 2025, 5:24 PM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 173.63 million as of November 19, 2025. Its market cap has increased by 20.28% in one year.
Market Cap
173.63M
Enterprise Value
226.17M
Revenue
-501.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
79.10
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 173.63M, an increase of 492.04%. That is a compound annual growth rate of 29.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 173.63M | 16.72% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 94.03B |
| Danel (Adir Yeoshua) | 2.78B |
| Kamada | 1.34B |
| Bait Bakfar | 1.09B |
| SofWave Medical | 1.03B |
| BrainsWay | 994.27M |
| Ilex Medical | 776.90M |
| Novolog (Pharm-Up 1966) | 672.31M |